| Alexander B Latty, MD | |
|
Melrose Medical Assocs, 792 Main Street, Melrose, MA 02176-2710 | |
| (781) 662-7037 | |
| Not Available |
| Full Name | Alexander B Latty |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 57 Years |
| Location | Melrose Medical Assocs, Melrose, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346259488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35729 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Of Haverhill | Lawrence, MA | Home health agency |
| Melrosewakefield Healthcare | Melrose, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Melrose Medical Associates | 1153456991 | 2 |
News Archive
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiaries, Barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have initiated a challenge of the patent listed by UCB Inc. in connection with its Xyzal(R) Tablets (levocetirizine dihydrochloride), 5mg.
Patients with high-grade gliomas who experience acute (early) neurological toxicity during their treatment were more likely to experience chronic (late) neurological toxicity and shortened overall survival, according to researchers from the Kimmel Cancer Center at Jefferson. The study will be presented at the 2010 ASCO Annual Meeting in Chicago (Abstract #2037).
› Verified 4 days ago
| Entity Name | Melrose Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497874994 PECOS PAC ID: 1153456991 Enrollment ID: O20100317001084 |
News Archive
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiaries, Barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have initiated a challenge of the patent listed by UCB Inc. in connection with its Xyzal(R) Tablets (levocetirizine dihydrochloride), 5mg.
Patients with high-grade gliomas who experience acute (early) neurological toxicity during their treatment were more likely to experience chronic (late) neurological toxicity and shortened overall survival, according to researchers from the Kimmel Cancer Center at Jefferson. The study will be presented at the 2010 ASCO Annual Meeting in Chicago (Abstract #2037).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander B Latty, MD Melrose Medical Assoc, 792 Main Street, Melrose, MA 02176-2710 Ph: (781) 662-7037 | Alexander B Latty, MD Melrose Medical Assocs, 792 Main Street, Melrose, MA 02176-2710 Ph: (781) 662-7037 |
News Archive
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiaries, Barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have initiated a challenge of the patent listed by UCB Inc. in connection with its Xyzal(R) Tablets (levocetirizine dihydrochloride), 5mg.
Patients with high-grade gliomas who experience acute (early) neurological toxicity during their treatment were more likely to experience chronic (late) neurological toxicity and shortened overall survival, according to researchers from the Kimmel Cancer Center at Jefferson. The study will be presented at the 2010 ASCO Annual Meeting in Chicago (Abstract #2037).
› Verified 4 days ago
Fadel Bofarrag, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 800-424-3672 Fax: 314-434-5939 | |
Prava Karki, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Mike H Summerer, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 585 Lebanon Street, Hallmark Health System, Melrose, MA 02176 Phone: 781-979-3342 | |
Mohender S Maan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose Wakefield Hospital, Melrose, MA 02176 Phone: 781-979-3000 | |
Dr. Erica L Brooks, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Rowe St, Suite 600, Melrose, MA 02176 Phone: 781-979-3440 Fax: 781-979-0258 | |
Dr. Raj P. Shah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 860-305-6911 | |
Ronald P Sen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Tremont St, #109, Melrose, MA 02176 Phone: 781-662-3310 Fax: 781-662-6403 |